arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

UTAH MEDICAL PRODUCTS INC

UTMD
$75.15 ▼ -1.57 (-2.05%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
68 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
82
Health
Excellent
Bullish
auto_awesome

Analytical Summary

UTAH MEDICAL PRODUCTS INC shows strong fundamentals with top-quartile Profit Margin (%) and Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $239.3M
Dividend Yield
Revenue Growth -14.3%
Op. Margin 31.1%
ROIC 1.8%
FCF / Share $0.39
Trailing P/E 89.5x
Price / Book 2.0x
FCF Yield 0.5%
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$8.53M
↓ -14.3%
Net Income Profit after all expenses
$2.60M
↓ -14.4%
Operating Margin Operating profit as % of sales
31.1%
↑ +5.6% 86th
FCF / Share Free cash flow per share
$0.39
↓ -58.1%
Long-Term Debt Long-term obligations
$0.00
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Profit Margin (%)Profit Margin (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
91
Returns
66
Financial Health
97
Cash Quality
75

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 18 years · 68 quarters